The stock of Definitive Healthcare Corp (DH) has gone down by -1.52% for the week, with a -51.13% drop in the past month and a -44.89% drop in the past quarter. The volatility ratio for the week is 8.65%, and the volatility levels for the past 30 days are 8.99% for DH. The simple moving average for the last 20 days is -35.02% for DH stock, with a simple moving average of -43.78% for the last 200 days.
Is It Worth Investing in Definitive Healthcare Corp (NASDAQ: DH) Right Now?
Additionally, the 36-month beta value for DH is 1.51. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 0 rating it as “overweight,” 8 rating it as “hold,” and 0 rating it as “sell.”
The public float for DH is 40.79M and currently, short sellers hold a 6.80% ratio of that float. The average trading volume of DH on March 14, 2025 was 878.71K shares.
DH) stock’s latest price update
The stock of Definitive Healthcare Corp (NASDAQ: DH) has decreased by -5.82 when compared to last closing price of 2.75. Despite this, the company has experienced a -1.52% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-04 that FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Kate Hastings, Definitive Healthcare’s new Chief Customer Officer an inducement award consisting of 172,414 time-based restricted stock units (“RSUs”) effective March 3, 2025 and granted Benjamin Graboske, Definitive Healthcare’s new EVP, Technology, Engineering and Chief Data Officer an inducement award consisting of 1,018,330 time-based RSUs, effective March 3, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Hastings’ and Mr. Graboske’s respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Analysts’ Opinion of DH
Many brokerage firms have already submitted their reports for DH stocks, with Barclays repeating the rating for DH by listing it as a “Underweight.” The predicted price for DH in the upcoming period, according to Barclays is $4 based on the research report published on January 13, 2025 of the current year 2025.
Stephens, on the other hand, stated in their research note that they expect to see DH reach a price target of $5. The rating they have provided for DH stocks is “Equal-Weight” according to the report published on December 20th, 2024.
BTIG Research gave a rating of “Buy” to DH, setting the target price at $7 in the report published on September 17th of the previous year.
DH Trading at -40.50% from the 50-Day Moving Average
After a stumble in the market that brought DH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.02% of loss for the given period.
Volatility was left at 8.99%, however, over the last 30 days, the volatility rate increased by 8.65%, as shares sank -50.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -38.77% lower at present.
During the last 5 trading sessions, DH fell by -1.52%, which changed the moving average for the period of 200-days by -53.67% in comparison to the 20-day moving average, which settled at $3.99. In addition, Definitive Healthcare Corp saw -36.98% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DH starting from Moschella William, who sale 45,000 shares at the price of $4.70 back on Dec 03 ’24. After this action, Moschella William now owns 433,830 shares of Definitive Healthcare Corp, valued at $211,500 using the latest closing price.
Moschella William, the Officer of Definitive Healthcare Corp, proposed sale 45,000 shares at $4.65 during a trade that took place back on Dec 03 ’24, which means that Moschella William is holding shares at $209,250 based on the most recent closing price.
Stock Fundamentals for DH
Current profitability levels for the company are sitting at:
- -1.33 for the present operating margin
- 0.71 for the gross margin
The net margin for Definitive Healthcare Corp stands at -1.64. The total capital return value is set at -0.36. Equity return is now at value -63.28, with -28.34 for asset returns.
Based on Definitive Healthcare Corp (DH), the company’s capital structure generated 0.36 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23. The debt to equity ratio resting at 0.57. The interest coverage ratio of the stock is -22.63.
Currently, EBITDA for the company is -567.24 million with net debt to EBITDA at -0.3. When we switch over and look at the enterprise to sales, we see a ratio of 1.75. The receivables turnover for the company is 4.74for trailing twelve months and the total asset turnover is 0.23. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.21.
Conclusion
In conclusion, Definitive Healthcare Corp (DH) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.